Cargando…
Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19
Little empirical data support the use of telemedicine to provide medical and developmental follow-up care to preterm and high-risk infants after hospital discharge. Nevertheless, the COVID-19 pandemic temporarily rendered telemedicine the only means by which to provide essential follow-up care to th...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022519/ https://www.ncbi.nlm.nih.gov/pubmed/33892961 http://dx.doi.org/10.1016/j.semperi.2021.151430 |
_version_ | 1783674946081259520 |
---|---|
author | DeMauro, Sara B. Duncan, Andrea F. Hurt, Hallam |
author_facet | DeMauro, Sara B. Duncan, Andrea F. Hurt, Hallam |
author_sort | DeMauro, Sara B. |
collection | PubMed |
description | Little empirical data support the use of telemedicine to provide medical and developmental follow-up care to preterm and high-risk infants after hospital discharge. Nevertheless, the COVID-19 pandemic temporarily rendered telemedicine the only means by which to provide essential follow-up care to this population. In this article we discuss our institution's experience with rapid implementation of telemedicine in a multi-site neonatal follow-up program as well as benefits and limitations of the use of telemedicine in this context. Finally, we discuss the current problems that must be solved in order to optimize telemedicine as a tool for providing comprehensive, multidisciplinary medical and developmental care to high risk infants and their families. |
format | Online Article Text |
id | pubmed-8022519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80225192021-04-06 Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19 DeMauro, Sara B. Duncan, Andrea F. Hurt, Hallam Semin Perinatol Article Little empirical data support the use of telemedicine to provide medical and developmental follow-up care to preterm and high-risk infants after hospital discharge. Nevertheless, the COVID-19 pandemic temporarily rendered telemedicine the only means by which to provide essential follow-up care to this population. In this article we discuss our institution's experience with rapid implementation of telemedicine in a multi-site neonatal follow-up program as well as benefits and limitations of the use of telemedicine in this context. Finally, we discuss the current problems that must be solved in order to optimize telemedicine as a tool for providing comprehensive, multidisciplinary medical and developmental care to high risk infants and their families. Elsevier Inc. 2021-08 2021-04-06 /pmc/articles/PMC8022519/ /pubmed/33892961 http://dx.doi.org/10.1016/j.semperi.2021.151430 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article DeMauro, Sara B. Duncan, Andrea F. Hurt, Hallam Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19 |
title | Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19 |
title_full | Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19 |
title_fullStr | Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19 |
title_full_unstemmed | Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19 |
title_short | Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19 |
title_sort | telemedicine use in neonatal follow-up programs – what can we do and what we can't – lessons learned from covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022519/ https://www.ncbi.nlm.nih.gov/pubmed/33892961 http://dx.doi.org/10.1016/j.semperi.2021.151430 |
work_keys_str_mv | AT demaurosarab telemedicineuseinneonatalfollowupprogramswhatcanwedoandwhatwecantlessonslearnedfromcovid19 AT duncanandreaf telemedicineuseinneonatalfollowupprogramswhatcanwedoandwhatwecantlessonslearnedfromcovid19 AT hurthallam telemedicineuseinneonatalfollowupprogramswhatcanwedoandwhatwecantlessonslearnedfromcovid19 |